Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Recommendations to the patient..
- Who it may be relevant to
- Registry conditions: Cardiovascular (CV) Risk. Basic parameters: 40 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk. This study aims to evaluate the effectiveness and feasibility of a cardiovascular prevention pathway delivered remotely through a digital application, comparing it with a traditional in-person care pathway.
Interventions
- Other Recommendations to the patient.
Recommendations to the patient
Primary outcome measures
- Blood pressure [Time frame: 12 months]
- number of cigarettes [Time frame: 24 months]
Secondary outcome measures (2)
- body weigh [Time frame: 24 months]
- number of daily steps [Time frame: 24 months]
Eligibility criteria
Inclusion criteria
- Age between 40 and 75 years
- hypertension
- hyperglycaemia
- type 2 diabetes not requiring insulin therapy
- dyslipidaemia
- active smoking
- overweight/grade I obesity
- Willingness to participate in follow-up visits over 24 months
Exclusion criteria
- previous myocardial infarction
- stroke
- transient ischemic attack
- coronary artery diseas
- peripheral arterial occlusive disease
- heart failure
- Type 1 or type 2 diabetes mellitus on insulin therapy
- Advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m²)
- Active cancer disease
- Severe obesity
- Inability to use digital tools
- Pregnancy
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
Italy · 1 center
- Maria Cecilia Hospital — Cotignola
Identifiers
NCT: NCT07608926 · DIGITAL PREV